Side Effects

Semaglutide Side Effects

You’ve probably seen the dueling headlines: semaglutide is a miracle, or it lands you in the ER. The truth is less frightening, more nuanced. Semaglutide’s side effects are real, overwhelmingly gut-related, and for most people they’re a rough first few weeks — not a permanent feature. Knowing what’s common, what’s rare, and when to get help changes everything.

Quick Answer

The most frequently reported semaglutide side effects are nausea, diarrhea, vomiting, constipation, abdominal pain, fatigue, and headache. In diabetes trials, nausea hits about 1 in 6 people; in weight-loss studies, nausea climbs to 30–44% and diarrhea to about 30%. Vomiting is roughly four times more likely than with a placebo. Most digestive symptoms begin within hours to a few days of an injection, easing as your body adjusts over two to four weeks. Nausea typically improves in under eight days, diarrhea often resolves within a few days to a week, vomiting clears quickly, while constipation can sometimes last several weeks. Serious complications like pancreatitis, gallbladder disease, and severe allergic reactions are much rarer but require immediate medical attention.

Why Semaglutide Hits the Gut So Hard

Semaglutide is a GLP-1 receptor agonist. It mimics a natural hormone that tells your pancreas to release insulin, your liver to make less sugar, and — critically — your stomach to empty more slowly. That slow emptying is deliberate: food hangs around longer, so you feel full faster. The queasiness isn’t an allergy; it’s the drug doing exactly what it’s designed to do. Severe nausea that prevents you from keeping down fluids can lead to dangerous dehydration and warrants a medical call.

How Long Do Side Effects Last, and When Do They Start?

Most gastrointestinal side effects hit within hours to a few days of an injection, especially after the first dose or a dose increase. They typically peak during dose escalation, so the trickiest period is the first two months. Nausea usually eases within 8 days; diarrhea often runs its course within a few days to a week; vomiting clears in days. Constipation is more stubborn — a median of 47 days in one analysis, meaning half of those affected deal with it for seven weeks or longer. Semaglutide has a half-life of about 7 days, so it takes roughly 5 weeks to leave your system completely. Symptoms can persist that long after stopping.

Tirzepatide vs. Semaglutide — The Side-Effect Profile Is Nearly Identical

Tirzepatide (Mounjaro, Zepbound) activates both GLP-1 and GIP receptors, so a natural question is whether it causes fewer stomach problems. The 2025 head-to-head SURMOUNT-5 trial found nearly identical nausea rates — 44% in both groups — and diarrhea in about 23%. Vomiting was slightly lower with tirzepatide (15% versus 21.3%), but the difference was modest. A 2026 systematic review in JCI reported overall gastrointestinal side effects at 40% for tirzepatide and 43% for semaglutide. Both drugs produce dose-dependent digestive side effects: higher doses make nausea and diarrhea more likely and more intense. Neither clearly wins on day-to-day tolerability.

Retatrutide — Not Yet Approved, Not Yet Comparable

Retatrutide is an investigational triple agonist (GLP-1, GIP, and glucagon) still in Phase 3 trials. No FDA-approved labeling exists as of mid-2026. Early trial data show a similar cluster of nausea, diarrhea, and constipation. Dysesthesia — odd touch sensitivities or tingling — has been noted more frequently with retatrutide, though it also appears on the Ozempic label for semaglutide and with tirzepatide at higher doses. Without an approved safety database, any comparison carries an asterisk. Retatrutide is not legally available outside clinical trials.

Compounded Semaglutide — Added Risks Beyond the Active Ingredient

Compounded semaglutide is not a generic. It’s mixed from bulk ingredients without the FDA oversight given to Ozempic and Wegovy. That changes the safety conversation entirely. As of April 2025, the FDA had received 520 adverse event reports for compounded semaglutide, and the American Diabetes Association formally advises against its use. Documented problems: people accidentally injecting 5 to 20 times the intended dose because they’re unfamiliar with insulin syringes, bacterial contamination leading to infections, and use of salt forms of semaglutide never studied in humans. When you hear “compounded semaglutide side effects,” you’re hearing the drug’s own effects tangled with contamination, dosing errors, and untested chemicals.

What We Know — and Don’t Know — About Long-Term Use

The longest randomized data come from the SELECT trial, which tracked people for up to 4 years and found no unexpected safety signals. Gut symptoms were worst during dose increases and then faded. Still, semaglutide first hit the U.S. market in 2017, so true decade-plus data don’t exist.

A Harvard/CDC analysis found that roughly 17% of semaglutide-related emergency department visits involved hypoglycemia — dangerously low blood sugar — even in people not taking other glucose-lowering drugs. Symptoms like confusion, shakiness, or loss of consciousness demand urgent help.

The FDA’s boxed warning about thyroid C-cell tumors comes from rodent studies. Human thyroid cells have far fewer GLP-1 receptors, and large studies to date have not found an increased thyroid cancer risk. However, a neck lump, hoarseness, or difficulty swallowing should still prompt a call to your doctor.

A 2024 study in JAMA Ophthalmology found an association between semaglutide and NAION, a type of sudden vision loss. That’s an observational signal, not proven cause-and-effect. But any sudden change in vision is a medical emergency.

Pancreatitis and gallbladder disease are recognized warnings. Severe abdominal pain, especially if it radiates to your back, requires immediate medical evaluation.

What the Internet Gets Wrong

“Ozempic face” and “Ozempic butt” aren’t unique drug side effects. They describe fat loss from rapid weight reduction — something any substantial weight drop can cause.

Gastroparesis (stomach paralysis) is often cited as a common danger. In reality, semaglutide deliberately slows gastric emptying, but diagnosed gastroparesis appears only in scattered case reports, not at high rates in clinical trials. A viral TikTok may label severe nausea as stomach paralysis when it’s the drug’s intended effect on a stretched timeline.

Social media numbers aren’t incidence rates. A 2026 analysis of over 400,000 Reddit posts found that 43.5% of users mentioning semaglutide or tirzepatide described side effects. That’s a help-seeking sample, not a controlled trial. Clinical data paints a cleaner picture.

“Ozempic” is not every GLP-1. Ozempic is semaglutide for diabetes; Wegovy is the same drug for weight loss. Tirzepatide is different. Retatrutide is investigational. Blurring these names blurs which side-effect profile you’re actually reading about.

Bottom Line

Semaglutide side effects are real, dose-dependent, and for most people temporary. The initial gut upset reflects how the drug works, not toxicity. Serious complications are rare but demand immediate attention. If you use an FDA-approved product with a structured dosing schedule, your experience will likely mirror published trial data. If you use a compounded version, the risks expand to include dosing errors and contamination that no clinical trial ever tested. Where you get the medication changes the safety conversation as much as the molecule itself.

Frequently Asked Questions

How long after a semaglutide injection do side effects start? Most gut symptoms appear within hours to a few days, especially after the first shot or a dose increase.

How long do semaglutide side effects last? Nausea typically improves within 8 days, vomiting in a few days, and diarrhea within a few days to a week. Constipation can last several weeks, with a median of 47 days. Most side effects ease within 2–4 weeks as your body adjusts.

Is tirzepatide or semaglutide worse for stomach issues? Their side-effect profiles are nearly identical. In the SURMOUNT-5 trial, nausea rates were both 44% and diarrhea about 23%. Vomiting was slightly lower with tirzepatide but not dramatically so.

What are the side effects of compounded semaglutide? They include the active drug’s known gut effects plus risks specific to compounding: dosing errors (sometimes massive overdoses), bacterial contamination, and untested salt forms. The FDA does not approve compounded semaglutide.

Are there long-term side effects of semaglutide? The SELECT trial followed people for up to 4 years and found no unexpected safety signals. Beyond that, long-term data don’t yet exist. The rodent thyroid tumor risk has not been seen in human studies, but monitoring continues.

This article is for general education only and does not replace medical advice from a licensed healthcare professional.